Clinical Trial

Transorb™ Self-Gripping Resorbable Mesh in High-risk Subjects Undergoing Open Repair of Ventral Hernia

Study acronym: RECOVER
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of RECOVER is to evaluate the performance and safety of Transorb™ self-gripping resorbable mesh in high-risk subjects (at least one risk factor impairing wound healing) when used for reinforcement of abdominal wall soft tissues in procedures involving open extraperitoneal ventral hernia repair, in clean (US); and clean and clean-contaminated (Europe) surgical fields (Centers for Disease Control and Prevention (CDC) Classification I and II. Data from this study will primarily be used to support market approval and European post-market clinical follow-up needs. Secondarily, data will be used for product marketing, future product development, and to support market release and maintenance in global geographies.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2024-06-07; most recent amendment 2026-07-14.
Status change: Recruiting → Active, Not Recruiting 2025-07-31
Status change: Not Yet Recruiting → Recruiting 2024-08-06
Trial Details
NCT Number NCT06449378
Lead Sponsor Medtronic - MITG
Conditions Hernia, Hernia, Ventral, Hernia, Abdominal, Hernia Abdominal Wall
Enrollment 163 participants
Start Date 2024-07-02
Primary Completion 2026-09-15 (estimated)
Study Completion 2030-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-15